I
nflammatory bowel disease (IBD) is an idiopathic immunemediated disease that affects the colon and small intestine. IBD is principally divided into the major disorders of Crohn's disease and ulcerative colitis (UC). It is estimated that over 60,000 children in the United States have IBD, which represents 5% of all IBD cases. 1 Approximately 20% of new IBD cases are diagnosed in patients younger than 20 years. IBD is a chronic disorder that is characterized by periods of stability, acute flare-ups, and possible progression throughout its natural course. In addition to the gastrointestinal symptoms of IBD, there are numerous clinically significant extraintestinal manifestations (EIMs), in which the musculoskeletal, hepatobiliary, ocular, integument, and renal systems are most commonly affected. 2 Urolithiasis is caused by the aggregation of mineral crystals within the kidneys, ureters, or bladder. Stone disease accounts for approximately 0.1% of all American pediatric hospital admissions and is more common in children with metabolic disorders. 3, 4 Several studies indicate an increasing incidence of pediatric urolithiasis in recent years. 5, 6 The diagnosis of pediatric urolithiasis can be challenging due to subtle clinical findings that may differ between adults and children. 7 Although adults classically present with sudden onset severe flank pain, urolithiasis in pediatric populations frequently presents with abdominal pain. 3, 8 Importantly, urinary stones can remain clinically silent for a significant period before causing symptoms. If left untreated, urolithiasis can compromise renal function.
Urolithiasis is an EIM of IBD in pediatric patients. Pediatric patients with IBD are believed to have a 1% to 2% incidence of nephrolithiasis, but few studies have explored specifically the rates of urolithiasis in pediatric IBD populations. 9 In addition, the outcomes and hospital course of pediatric IBD patients with urolithiasis are unclear. Accurate and early diagnosis and treatment of IBD EIMs is necessary to prevent potential negative outcomes and to reduce excess health care resource utilization. Several large population studies of pediatric IBD EIMs discuss nephrolithiasis as a potential complication of IBD, but no studies evaluate data regarding patient diagnosis, management, and outcomes. 10, 11 In this study, we hypothesized that there is an association between IBD and urolithiasis in hospitalized pediatric patients. In addition, we aimed to determine diagnostic and therapeutic procedure rates, postprocedural complications, hospital length of stay (LOS), and hospitalization costs associated with urolithiasis in hospitalized pediatric patients with IBD.
METHODS

Data Source
The triennial Healthcare Cost and Utilization Project Kids' Inpatient Database (HCUP-KID) for years 1997, 2000, 2003, 2006, 2009 , and 2012 was used to perform a cross-sectional inpatient study of urolithiasis and its association with IBD. 12 
Variable Definition
The database was first limited to subjects aged 5 to 20 years old, and any hospitalizations related to pregnancy and peripartum complications were excluded. Children younger than 5 years were excluded to reduce likelihood of including phenotypically distinct early-onset and very early-onset IBD. IBD status was defined as the hospital record containing a secondary diagnosis of IBD (diagnosis number 2-15 or 2-25, depending on the year), using the ICD-9-CM diagnosis codes for Crohn's disease (555.xx) and UC (556.xx). To avoid misclassification bias, hospital records in which there was both a diagnosis of Crohn's disease and UC were excluded from both groups for analyses. Urolithiasis hospitalizations were defined by the presence of primary diagnosis codes for urolithiasis (ICD-9-CM 592.0, 592.1, 592.9, 594.0, 594.1, 594.2, 594.8, 594.9, 788.0, V13.01).
The interventions for urolithiasis were identified using ICD-9-CM procedure codes categorized with the assistance of the HCUP Clinical Classifications Software for Services and Procedures (CCS-Services and Procedures). 13 22) , urinary complications (ICD-9-CM 997.5), and acute renal failure (ICD-9-CM 584.x, 586.x). [14] [15] [16] LOS was evaluated as the number of days hospitalized. Costs of hospitalization were only available for years 2003, 2006, 2009, and 2012 . The costs were inflation adjusted to January 2017 dollars using the U.S. consumer price index for inpatient hospital services. 17 Demographic information available included age, sex, race, insurance type, and geographic region. Race and ethnicity reporting vary by state, so the race/ethnicity variable was categorized into white, black, Hispanic, other race/ethnicity, and not reported or missing. Insurance type was divided into private (health maintenance organization/private insurance), public (Medicare/Medicaid), and uninsured (self-pay, no-pay, and any other). Hospital geographic regions were assigned per HCUP-KID to Northeast, Midwest, South, or West. 12 
Statistical Analysis
Unless otherwise noted, all numbers presented accounted for and used the provided population weights as recommended by HCUP-KID documentation. 12 All analyses also used the HCUP-KID-provided weights and accounted for the survey design of the database. Continuous data were summarized as mean values with 95% confidence intervals (95% CIs), and categorical data were given as frequencies and percentages. Descriptive summary totals, urolithiasis procedures, and postprocedural complications were compared by IBD status (Crohn's disease, UC, and non-IBD) using Rao-Scott chisquare tests. The age at admission was compared between IBD statuses using a weighted analysis of variance.
The association between IBD and urolithiasis was evaluated using a multivariable logistic regression model. The presence or absence of urolithiasis was the dichotomous dependent variable, and independent variables included sex, age, race, hospital region, payer type, and a 3-level categorical variable representing IBD (Crohn's disease, UC, and non-IBD). We used a generalized linear model to estimate and compare the continuous variables cost and LOS, between urolithiasis patients with and without IBD. A gamma distribution was used to model cost. LOS was modeled using a negative binomial distribution. Crohn's disease and UC were evaluated along with other covariates, such as age, sex, race/ethnicity, insurance, year, and hospital region. Least-squares estimates and 95% CIs of the LOS and costs were obtained from the fitted models. Statistical analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC), and all statistical tests were performed at a significance level of a ¼ 0.05.
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RESULTS
We identified a total weighted sample of 8,828,522 hospital admissions in a patient age range of 5 to 20 years old (Table 1) . Within this population, there were 36,771 weighted admissions with a primary diagnosis of urolithiasis. There were 19,920 and 11,367 weighted admissions with a secondary diagnosis of Crohn's disease and UC, respectively. There were 189 weighted hospitalizations with a diagnosis of both UC and Crohn's disease, and among this group, there was 1 case with urolithiasis. Because of ambiguity of their underlying disease process, patients with both Crohn's disease and UC were excluded from further analyses. A primary diagnosis of urolithiasis was present in 332 admissions with a secondary IBD diagnosis; 230 had Crohn's disease and 102 had UC.
Pediatric patients with a secondary diagnosis of any IBD type were significantly more likely than those without IBD to have a hospitalization related to urolithiasis (odds ratio ¼ 1.91; 95% CI, 1.66-2.19). Pediatric patients hospitalized with urolithiasis and IBD were disproportionately older, female, white, privately insured, and geographically located outside the West compared with those without IBD (P , 0.001).
An inpatient diagnosis of urolithiasis was associated with a secondary diagnosis of Crohn's disease (odds ratio, 2.03; 95% CI, 1.78-2.32) and UC (odds ratio, 1.68; 95% CI, 1.38-2.05) ( Table 2 ). Older age, female sex, white race, having private insurance, and living outside the Western United States were also associated with urolithiasis hospitalizations.
The overall frequency of urological procedures in patients with a primary diagnosis of urolithiasis was significantly lower in patients with IBD (P ¼ 0.005) ( Table 3 ). Further subgroup analysis comparing children with urolithiasis and Crohn's disease to those with urolithiasis and UC demonstrated no significant difference overall in the frequency of urological procedures. There were no cases of the adapted ACS NSQIP posturological procedure complications of surgical site infections (superficial or deep), urinary complications, or peritoneal abscess formation, among those with Crohn's disease or UC. Among non-IBD patients, there were no cases of deep surgical site infections, 2 cases of superficial surgical site infections, 3 cases of peritoneal abscess, and 46 cases of urinary complications. There were 5 cases of acute renal failure in urolithiasis patients with IBD and 371 in those without IBD (P ¼ 0.30). LOS for urolithiasis was significantly longer in pediatric patients with UC compared with those without IBD, but not those with Crohn's disease. There were also significantly greater financial costs associated with pediatric urolithiasis in patients with comorbid UC, but not Crohn's disease. There was no significant difference between the adjusted costs per hospital day for those without IBD and those with UC or Crohn's disease. Urologic procedures were associated with a significant increased adjusted cost per day (P , 0.001), but there was no significant difference in the adjusted cost per day between non-IBD, UC, and Crohn's disease patients who had procedures.
DISCUSSION
Among pediatric and adolescent patients, there is a statistically significant association between IBD and urolithiasis. Compared with patients without IBD who were admitted for urolithiasis, patients with UC had increased LOS and costs but received fewer overall stone-related procedural interventions. Patients with Crohn's disease had similar LOS and costs to those without IBD but also received fewer overall stone-related procedural interventions. Evaluated posturological procedure complications were rare in children with and without IBD.
Studies in adult populations have noted that urolithiasis is a common EIM of IBD, but it may be less common in pediatric and adolescent patients. 9, 18 An overlap of symptoms, especially abdominal pain, may make it clinically challenging to diagnose urolithiasis in children with comorbid IBD. 19 In addition, milder presentations of urolithiasis in young patients may reduce provider suspicion of an alternate etiology to typical IBD pain symptoms. These factors place children with IBD at potentially serious risk for delayed or missed diagnosis of urolithiasis. A better understanding of urolithiasis as an EIM of IBD may lead to earlier diagnosis and potentially reduce the need for hospitalization.
The epidemiology of pediatric urolithiasis has been evaluated previously, but there is currently little consensus on the role of several key demographic risk factors. 20 Epidemiological factors affecting stone risk in patients with IBD are less frequently studied and are likewise poorly understood. This study found that, among all pediatric urolithiasis hospitalizations, female sex, older age, white race, non-Western hospital geographic region, and possession of private insurance were all associated with urolithiasis.
Previous studies of pediatric urolithiasis differ on male or female sex as a risk factor. 20, 21 We found that female sex was associated with an increased incidence of hospitalization for urolithiasis. Females with certain risk variables, including elevated body mass index and hypertension, may have increased sensitivity to physiologic changes that can result in urolithiasis. 22 Paralleling our findings, a recent large retrospective study in Taiwan found that the incidence of nephrolithiasis was significantly higher in the older pediatric cohorts. 20 Previous studies have found that white patients are at greater risk of stone disease, but a recent review Costs were consumer product index adjusted for hospital inpatient services to January 2017 dollars. Comparisons are between IBD type and non-IBD.
failed to reveal compelling evidence to explain the role of race in stone formation. 23 Higher urolithiasis rates have been previously noted within the Southern U.S. region, suggesting that warmer climate or geographically variable groundwater minerals may play an important role in stone formation. 24 Hospital setting and socioeconomic variables have been evaluated previously as risk factors for stone disease with results that vary depending on the country of origin. For the U.S. population in this study, hospitalizations for urolithiasis in patients with comorbid IBD were more common among patients with private insurance, suggesting that patients with public insurance or no insurance were admitted less frequently for urolithiasis. Patients with public insurance or no insurance may present less frequently because of decreased access to care, although previous American adult population studies have found that lower socioeconomic status is associated with a previous diagnosis of kidney stones. 25 The discrepancy between hospitalization frequency by insurance type identified in our study, and previous reports of higher stone incidence in patients of lower socioeconomic statuses, suggests that access to care may lead to underestimation of urolithiasis incidence in patients with IBD. Importantly, the higher rate of hospital admission among those with private insurance may represent a health care disparity.
No previous studies have evaluated the financial burden associated with concomitant pediatric urolithiasis and IBD. Previous studies have found that the general pediatric population with urolithiasis has increased health care costs compared with adults. 26 Pediatric urolithiasis patients with UC had increased LOS and costs, but, interestingly, had fewer overall procedures than non-IBD patients. This indicates that increased LOS and additional nonprocedural medical demands may increase the financial burden caused by pediatric stone formers with IBD. Inpatient procedures, including imaging studies or nonurological surgeries or interventions, may account for some of the difference in costs. Urolithiasis patients with IBD may be more ill, have more advanced stone disease, or may be worse surgical candidates than the general pediatric stone population, lowering a provider's tendency to manage their stones with an invasive inpatient procedure. In addition, patients with IBD frequently take immunosuppressive medications that may prolong inpatient recovery, making medical management of stones preferred.
We evaluated several posturological procedure complications, including surgical site infections (superficial and deep), peritoneal abscess formation, and urinary complications, and found no significant differences in postoperative complication rates among IBD or non-IBD patients who underwent one of the evaluated procedures. The absolute number of complications was rare overall, making any clinically relevant conclusions difficult. Although the current study suggests that there is no increased risk of posturological procedure complications in patients with IBD, a perceived risk of negative outcomes of invasive procedures in children with IBD also may lead providers to choose nonoperative management. Surgical patients must be carefully selected, and nonoperatively managed patients may require prolonged hospital stays and monitoring that could lead to overall more costly hospitalizations. Another possible explanation, however, is that a child who is known to have IBD may present with symptoms of urolithiasis, be hospitalized for the presenting abdominal pain, and undergo an inpatient diagnostic evaluation where the final diagnosis is urinary calculus. Alternatively, some degree of sampling bias may occur within our study population because patients with IBD could be admitted more often with incidental, less asymptomatic stones, discovered during abdominal imaging related to IBD.
Within the general pediatric population, the evaluated urologic urolithiasis procedures are generally successful and have low complication rates. 27 Postoperative complications in pediatric urolithiasis patients with comorbid IBD have not been studied previously. Our analysis was limited to postoperative complications that occurred during the patient's urolithiasis hospitalization and did not include complications at outpatient postprocedural follow-up. Longitudinal study of complications and recurrence rates are necessary to gain a clearer understanding of the risks and benefits associated with procedural interventions in this population.
Retrospective studies that use HCUP-KID data are limited by their reliance on billing codes and thus are prone to misclassification bias. The HCUP-KID represents cross-sectional inpatient subjects and thus does not allow for calculation of incidence and population risk. HCUP-KID data is deidentified, so patient information is not available to track outpatient data before, or after, discharge. This is relevant to urolithiasis outcomes because urolithiasis patients, even within the pediatric population, often have recurrence. 28 We are unable to account for individual patients with multiple hospitalizations through exclusion of subsequent encounters. We are also unable to evaluate individual risk factors, such as nutritional status, which may account for an increased cost or LOS independent urolithiasis. Our study was strengthened by HCUP KID's large population, which included 8,828,902 hospitalizations. This large size allows for the evaluation of rare conditions and associations among pediatric patients. HCUP-KID also has diversity of sex, race, socioeconomic status, and geographic region that is representative of pediatric hospitalizations nationwide.
Our findings indicate that there may be room to improve urolithiasis prevention, diagnosis, and management within the IBD population. Pediatric patients with IBD should be aware of simple prevention techniques, including dietary modifications and adequate hydration, and should be counseled at diagnosis about the signs and symptoms of stone disease. Providers should be aware that this population might have significant symptom overlap between stone and IBD-related pain. Increased clinical suspicion may allow for early outpatient management and may avoid expensive and invasive inpatient workups.
Providers should have an increased index of suspicion of stone disease in pediatric and adolescent patients with IBD, as they are at increased risk of urinary tract calculi that can lead to prolonged admissions. Urolithiasis prevention through early patient education and accurate diagnosis in patients with IBD is vital to prevent and reduce unnecessary costs and adverse outcomes.
